Medical research

Novel inhibitor discovered for B-cell lymphoma treatment

A potent and selective enhancer of zeste homolog 2 (EZH2) inhibitor IHMT-EZH2-115 was recently discovered by researchers led by Prof. Liu Qingsong from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences ...

Oncology & Cancer

Radiotherapy-induced autophagy may enhance modulation of cell cycle

Building on prior success combining Cyclin-Dependent Kinase (CDK) inhibitors with hormone therapy to treat breast cancer, researchers are now exploring the potential integration of CDK inhibitors with radiotherapy in a paper ...

Diseases, Conditions, Syndromes

COVID-19: Biomarkers linked to severe forms of the disease

Recent studies have shown that immune response plays a central role in the severity of COVID-19. Understanding the immune responses generated as the disease progresses is therefore key to determining which patients are at ...

page 7 from 40